Japanese Companies Set to Acquire Stake in Chinese Medicine Firm

By
Shinji Yamaguchi
1 min read
⚠️ Heads up: this article is from our "experimental era" — a beautiful mess of enthusiasm ✨, caffeine ☕, and user-submitted chaos 🤹. We kept it because it’s part of our journey 🛤️ (and hey, everyone has awkward teenage years 😅).

A group led by Japan’s Mitsui & Co. and Rohto Pharmaceutical Co. is close to securing a majority stake in Eu Yan Sang International Ltd., a medicine and health-care company. This Japanese consortium has emerged as the leading contender after outbidding others. Sources familiar with the matter revealed that the companies are in the final stages of negotiating the deal, which could be sealed as early as next week. The identity of the sources is withheld due to the sensitivity of the matter.

You May Also Like

This article is submitted by our user under the News Submission Rules and Guidelines. The cover photo is computer generated art for illustrative purposes only; not indicative of factual content. If you believe this article infringes upon copyright rights, please do not hesitate to report it by sending an email to us. Your vigilance and cooperation are invaluable in helping us maintain a respectful and legally compliant community.

Subscribe to our Newsletter

Get the latest in enterprise business and tech with exclusive peeks at our new offerings

We use cookies on our website to enable certain functions, to provide more relevant information to you and to optimize your experience on our website. Further information can be found in our Privacy Policy and our Terms of Service . Mandatory information can be found in the legal notice